Understanding MDD Treatments With Neuroplastic Effects
Researchers are exploring whether it is possible to leverage neuroplasticity to develop treatments for depression. Read More
- About
- PsychU For You
- Topics
- Events
- Content
Neuroplasticity
Understanding Neuroplasticity In Depression
The brain is constantly changing! The ability of the brain to create, reorganize, or eliminate connections between neurons (synapses) and change how its circuits are wired is called neuroplasticity. Read MoreFollow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia
During this question and answer session, Dr. Laura Rowland responds to unanswered questions from the PsychU webinar, “The Role of Glutamate in Mood Disorders & Schizophrenia,” which took place on… Read MoreRevisiting Cognitive Deficits In Bipolar Disorder
Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read MoreThe Neurobiology Of Opioids
Hear from Chip Meyer, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as he examines the historic medical utilization and underlying neurobiological mechanisms of opioids. Explore… Read MoreDepression: From Molecule To Man
Dr. Mark M. Rasenick examines the impact of depression in molecules, rodents, primates, and humans from a biological, genetic, and epigenetics perspective. Dr. Rasenick identifies the importance of research derived… Read MoreEvolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis
According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are… Read MoreWebinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis
This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/evolving-pharmacology-depression-beyond-monoamine-hypothesis/. On October 9, 2018,… Read MoreTreating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions
Key Messages The postsynaptic density (PSD) is a specialized ultrastructure located in the membrane of glutamatergic synapses where cross-talk between glutamate and dopamine signaling pathways can occur. Abnormal expression and… Read MoreThe Neurobiology Of Motivational Deficits In Depression – An Update On Candidate Pathomechanisms
Key Messages Anhedonia is closely associated with depression. Two important components of anhedonia are impairments in motivation and reinforcement learning. Evidence suggested that patients with depression tend to show reduced… Read More - PsychU For You
